News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
704,732 Results
Type
Article (62111)
Company Profile (159)
Press Release (642462)
Multimedia
Podcasts (76)
Webinars (13)
Section
Business (187806)
Career Advice (2887)
Deals (35046)
Drug Delivery (113)
Drug Development (80103)
Employer Resources (166)
FDA (16284)
Job Trends (15351)
News (328934)
Policy (33235)
Tag
Academia (2866)
Academic (2)
Accelerated approval (6)
Adcomms (25)
Allergies (93)
Alliances (47223)
ALS (97)
Alzheimer's disease (1400)
Antibody-drug conjugate (ADC) (129)
Approvals (16275)
Artificial intelligence (290)
Autoimmune disease (25)
Automation (16)
Bankruptcy (335)
Best Places to Work (12099)
BIOSECURE Act (19)
Biosimilars (115)
Biotechnology (96)
Bladder cancer (81)
Brain cancer (29)
Breast cancer (297)
Cancer (2301)
Cardiovascular disease (183)
Career advice (2444)
Career pathing (33)
CAR-T (166)
Cell therapy (454)
Cervical cancer (22)
Clinical research (65165)
Collaboration (855)
Company closure (2)
Compensation (351)
Complete response letters (22)
COVID-19 (2752)
CRISPR (47)
C-suite (272)
Cystic fibrosis (106)
Data (2296)
Decentralized trials (2)
Denatured (31)
Depression (47)
Diabetes (278)
Diagnostics (6665)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (41)
Drug discovery (124)
Drug pricing (115)
Drug shortages (24)
Duchenne muscular dystrophy (94)
Earnings (68316)
Editorial (42)
Employer branding (21)
Employer resources (146)
Events (113240)
Executive appointments (782)
FDA (17686)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (797)
Gene editing (117)
Generative AI (25)
Gene therapy (315)
GLP-1 (748)
Government (5012)
Grass and pollen (6)
Guidances (145)
Healthcare (20102)
Huntington's disease (21)
IgA nephropathy (25)
Immunology and inflammation (127)
Indications (30)
Infectious disease (2907)
Inflammatory bowel disease (149)
Inflation Reduction Act (11)
Influenza (57)
Intellectual property (100)
Interviews (545)
IPO (16141)
IRA (44)
Job creations (3702)
Job search strategy (2050)
Kidney cancer (10)
Labor market (35)
Layoffs (528)
Leadership (23)
Legal (7602)
Liver cancer (76)
Lung cancer (316)
Lymphoma (149)
Machine learning (9)
Management (59)
Manufacturing (321)
MASH (73)
Medical device (13885)
Medtech (13890)
Mergers & acquisitions (19503)
Metabolic disorders (717)
Multiple sclerosis (87)
NASH (17)
Neurodegenerative disease (88)
Neuropsychiatric disorders (27)
Neuroscience (1958)
NextGen: Class of 2025 (7043)
Non-profit (4888)
Now hiring (17)
Obesity (379)
Opinion (245)
Ovarian cancer (79)
Pain (99)
Pancreatic cancer (87)
Parkinson's disease (151)
Partnered (21)
Patents (246)
Patient recruitment (117)
Peanut (50)
People (60882)
Pharmaceutical (44)
Pharmacy benefit managers (21)
Phase I (20409)
Phase II (28550)
Phase III (21235)
Pipeline (1319)
Policy (163)
Postmarket research (2687)
Preclinical (8617)
Press Release (67)
Prostate cancer (110)
Psychedelics (36)
Radiopharmaceuticals (263)
Rare diseases (391)
Real estate (6183)
Recruiting (67)
Regulatory (22860)
Reports (34)
Research institute (2535)
Resumes & cover letters (441)
Rett syndrome (5)
RNA editing (4)
RSV (44)
Schizophrenia (72)
Series A (136)
Series B (91)
Service/supplier (11)
Sickle cell disease (57)
Special edition (14)
Spinal muscular atrophy (154)
Sponsored (32)
Startups (3571)
State (1)
Stomach cancer (11)
Supply chain (64)
Tariffs (39)
The Weekly (43)
Vaccines (765)
Venture capitalists (42)
Weight loss (247)
Women's health (37)
Worklife (19)
Date
Today (239)
Last 7 days (935)
Last 30 days (3061)
Last 365 days (32735)
2025 (11760)
2024 (35021)
2023 (39679)
2022 (50769)
2021 (55878)
2020 (55090)
2019 (48996)
2018 (37217)
2017 (33038)
2016 (32889)
2015 (38456)
2014 (31369)
2013 (27263)
2012 (28754)
2011 (29089)
2010 (27465)
Location
Africa (977)
Alabama (59)
Alaska (7)
Arizona (198)
Arkansas (13)
Asia (40820)
Australia (7226)
California (6156)
Canada (2044)
China (534)
Colorado (274)
Connecticut (290)
Delaware (155)
Europe (94467)
Florida (928)
Georgia (223)
Hawaii (1)
Idaho (62)
Illinois (590)
India (27)
Indiana (332)
Iowa (9)
Japan (167)
Kansas (109)
Kentucky (25)
Louisiana (12)
Maine (70)
Maryland (926)
Massachusetts (4563)
Michigan (236)
Minnesota (386)
Mississippi (2)
Missouri (91)
Montana (31)
Nebraska (25)
Nevada (67)
New Hampshire (70)
New Jersey (1778)
New Mexico (29)
New York (1794)
North Carolina (1024)
North Dakota (9)
Northern California (2693)
Ohio (208)
Oklahoma (15)
Oregon (37)
Pennsylvania (1359)
Puerto Rico (13)
Rhode Island (31)
South America (1298)
South Carolina (22)
South Dakota (1)
Southern California (2325)
Tennessee (106)
Texas (921)
United States (23557)
Utah (198)
Virginia (152)
Washington D.C. (65)
Washington State (572)
West Virginia (3)
Wisconsin (64)
704,732 Results for "harvard school of public health".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sixty Degrees Pharmaceuticals Announces Patent License Agreement to Advance Development of Tafenoquine for Babesiosis Treatment and Prevention with Yale School of Medicine and Yale School of Public Health
April 8, 2025
·
10 min read
Press Releases
Cellares and University of Wisconsin School of Medicine and Public Health to Automate Clinical-Scale Production of CRISPR-Edited CAR-T for Solid Tumors
April 10, 2025
·
5 min read
Infectious disease
Small Harvard Start-Up Launches to Fight Huge Problem of Antimicrobial Resistance
The World Health Organization names antimicrobial resistance as one of the most urgent public health threats, but it remains an unattractive target for the pharmaceutical industry due to its weak profitability.
February 24, 2025
·
2 min read
·
Tristan Manalac
Business
Healis Therapeutics announces collaboration with Massachusetts General Hospital (MGH) and affiliates of Harvard Medical School to advance clinical-stage neuroscience research
Healis Therapeutics is pleased to announce that it has entered a clinical collaboration with Massachusetts General Hospital (MGH), a founding member of the Mass General Brigham health system, and affiliates of Harvard Medical School (HMS).
March 26, 2024
·
1 min read
Press Releases
MIMEDX Announces Publication of Health Economics Data in Mohs Micrographic Surgery (MMS)
May 5, 2025
·
2 min read
IN PARTNERSHIP WITH DIA
Eroding Immunity: Vaccine Hesitancy and Cynicism With Paul Offit
In this episode of Denatured BioSpace’s head of insights Lori Ellis discusses the public health consequences of vaccine hesitancy and the critical distinction between skepticism and cynicism with Paul Offit, MD, director of the Vaccine Education Center at the Children’s Hospital of Philadelphia.
May 8, 2025
·
1 min read
·
Lori Ellis
Press Releases
Esteemed Harvard Medical School Professor Dr. Michael Gibson Appointed Chief Medical Advisor at Lexaria Bioscience
December 17, 2024
·
5 min read
Press Releases
Harvard Bioscience Announces CFO Transition
April 11, 2025
·
3 min read
Government
Democrats Push Back on Trump Health Cuts With Lawsuits and Longest Ever Senate Speech
Nearly two dozen states on Tuesday sued the Department of Health and Human Services over a planned $11 billion funding cut for public health projects while New Jersey Senator Cory Booker spoke for 25 hours in protest of Trump administration policies.
April 2, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Roche announces launch of Roche Genentech Innovation Center Boston based at Harvard’s Enterprise Research Campus in Allston
March 7, 2025
·
6 min read
1 of 70,474
Next
